Cryoablation Combined With Sintilimab Plus Regorafenib In Previously Treated Colorectal Cancer Liver Metastasis
Status:
Recruiting
Trial end date:
2024-09-25
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of cryoablation combined
with Sintilimab plus regorafenib for patients with colorectal cancer liver metastasis in the
third-line setting.